Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product

Target Oncol. 2020 Dec;15(6):807. doi: 10.1007/s11523-020-00772-4.

Abstract

Page 608, 4 Discussion, right column, second paragraph.

Publication types

  • Published Erratum